                               SEQUENCE LISTING

<110> FENG, XIAODONG
 
<120> ADMINISTRATION OF AN ANTAGONIST OF ALPHA5BETA1 FOR 
      ANTI-ANGIOGENESIS AND CANCER TREATMENT

<130> CALPP002.US01

<140> 13/374,369
<141> 2011-12-22

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 65
<212> PRT
<213> Vipera lebetina

<400> 1
Met Asn Ser Gly Asn Pro Cys Cys Asp Pro Val Thr Cys Lys Pro Arg 
1               5                   10                  15      


Arg Gly Glu His Cys Val Ser Gly Pro Cys Cys Arg Asn Cys Lys Phe 
            20                  25                  30          


Leu Asn Ala Gly Thr Ile Cys Lys Arg Ala Arg Gly Asp Asp Met Asn 
        35                  40                  45              


Asp Tyr Cys Thr Gly Ile Ser Pro Asp Cys Pro Arg Asn Pro Trp Lys 
    50                  55                  60                  


Gly 
65  


<210> 2
<211> 137
<212> PRT
<213> Vipera palestinae


<220>
<221> MOD_RES
<222> (99)..(124)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (134)..(137)
<223> Any amino acid

<400> 2
Asp Gln Asp Cys Leu Pro Gly Trp Ser Phe Tyr Glu Gly Asn Cys Tyr 
1               5                   10                  15      


Lys Ala Phe Asp Glu Pro Lys Ser Trp Val Asp Ala Glu Lys Phe Cys 
            20                  25                  30          


Gln Lys Gln Ser Asn Gly Lys His Leu Ala Ser Ile Glu Gly Leu Gly 
        35                  40                  45              


Lys Ala Asn Phe Val Ala Lys Leu Val Ser Glu Asp Gln Ser Glu Thr 
    50                  55                  60                  


Leu Arg Glu Pro Gln Ile His Val Trp Ile Gly Leu Arg Asp Gln Ser 
65                  70                  75                  80  


Glu Arg Gln Gln Cys Ser Ser His Trp Thr Asp Gly Ser Ala Val Ser 
                85                  90                  95      


Tyr Glu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            100                 105                 110         


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys Gly Leu Ala 
        115                 120                 125             


Tyr Pro Phe Ile Cys Xaa Xaa Xaa Xaa 
    130                 135         


<210> 3
<211> 125
<212> PRT
<213> Vipera palestinae

<400> 3
Asp Gln Asp Cys Leu Pro Gly Trp Ser Tyr Phe Glu Lys Tyr Cys Tyr 
1               5                   10                  15      


Lys Val Phe Gln Val Lys Lys Asn Trp Glu Asp Ala Glu Lys Phe Cys 
            20                  25                  30          


Thr Glu Glu Val Lys Asp Gly His Leu Ile Ser Leu His Ser Asn Glu 
        35                  40                  45              


Glu Val Glu Phe Met Thr Ser Leu Ala Phe Pro Ile Leu Lys Tyr Asp 
    50                  55                  60                  


Ile Val Trp Met Gly Leu Arg Asn Phe Trp Arg Asp Cys Pro Trp Lys 
65                  70                  75                  80  


Trp Ser Asp Asp Ala Lys Leu Asp Tyr Lys Ala Trp Ser Asp Glu Pro 
                85                  90                  95      


Asn Cys Tyr Gly Ala Met Thr Thr Asp Tyr Gln Trp Leu Arg Trp Asn 
            100                 105                 110         


Cys Asn Asp Pro Arg Tyr Phe Val Cys Lys Ser Pro Ala 
        115                 120                 125 


<210> 4
<211> 49
<212> PRT
<213> Echis carinatus

<400> 4
Gln Cys Glu Ser Gly Pro Cys Cys Arg Asn Cys Lys Phe Leu Lys Glu 
1               5                   10                  15      


Gly Thr Ile Cys Lys Arg Ala Arg Gly Asp Asp Met Asp Asp Tyr Cys 
            20                  25                  30          


Asn Gly Lys Thr Cys Asp Cys Pro Arg Asn Pro His Lys Gly Pro Ala 
        35                  40                  45              


Thr 
    


<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Pen

<400> 5
Gly Xaa Gly Arg Gly Asp Ser Pro Cys Ala 
1               5                   10  


<210> 6
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gly Arg Gly Glu Ser Pro 
1               5       


